Wordt geladen...
Matrine in association with FD-2 stimulates F508del-cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809
Cystic fibrosis is caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, and the predominant mutation is termed Phe508del (F508del). Therapy for F508del-CFTR patients is based on the use of Orkambi(®), a combination of VX809 and VX770. However, though Orkambi le...
Bewaard in:
| Gepubliceerd in: | Mol Med Rep |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5779973/ https://ncbi.nlm.nih.gov/pubmed/29039559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.7736 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|